Downregulation of EVI1 Expression Inhibits Cell Proliferation and Induces Apoptosis in Hilar Cholangiocarcinoma via the PTEN/AKT Signalling Pathway

por Zhang, Xiao-ming, Liu, Zeng-li, Qiu, Bo, XU, Yun-fei, Pan, Chang, Zhang, Zong-li
Publicado 2020

Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma

por Zhao, Li-ming, Shi, An-da, Yang, Yan, Liu, Zeng-li, Hu, Xiao-Qiang, Shu, Li-Zhuang, Tang, Yong-chang, Zhang, Zong-li
Publicado 2023

Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling

por Xu, Yun‐Fei, Liu, Hong‐Da, Liu, Zeng‐Li, Pan, Chang, Yang, Xiao‐Qing, Ning, Shang‐Lei, Zhang, Zong‐Li, Guo, Sen, Yu, Jin‐Ming
Publicado 2018

Decreased expression of serum semaphorin 3B is associated with poor prognosis of patients with hepatocellular carcinoma

por Li, Guang-Zhen, Shen, Di, Li, Guang-Hong, Wei, Meng, Zheng, Li-Jie, Liu, Zeng-Li, Sun, Rong-Qi, Zhou, Shao-Jun, Zhang, Zong-Li, Gao, Yan-Chao
Publicado 2021

Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers

por Li, Yun-cheng, Li, Kang-shuai, Liu, Zeng-li, Tang, Yong-chang, Hu, Xiao-Qiang, Li, Xing-yong, Shi, An-da, Zhao, Li-ming, Shu, Li-Zhuang, Lian, Shuo, Yan, Zhang-di, Huang, Shao-hui, Sheng, Guo-li, Song, Yan, Liu, Yun-jia, Huan, Fan, Zhang, Ming-hui, Zhang, Zong-li
Publicado 2022